Results
|
|
2921.
|
|
|
|
2922.
|
|
|
|
2923.
|
|
|
|
2924.
|
|
|
|
2925.
|
|
|
|
2926.
|
|
|
|
2927.
|
Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety. [electronic resource] by
- Ryan, Patricia C
- Sleeman, Matthew A
- Rebelatto, Marlon
- Wang, Bing
- Lu, Hong
- Chen, Xiaomin
- Wu, Chi-Yuan
- Hinrichs, Mary Jane
- Roskos, Lorin
- Towers, Heidi
- McKeever, Kathleen
- Dixit, Rakesh
Producer: 20141012
In:
Toxicology and applied pharmacology vol. 279
Availability: No items available.
|
|
|
2928.
|
|
|
|
2929.
|
|
|
|
2930.
|
|
|
|
2931.
|
|
|
|
2932.
|
|
|
|
2933.
|
|
|
|
2934.
|
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor. [electronic resource] by
- Yasuda, Nobuyuki
- Nagakura, Tadashi
- Inoue, Takashi
- Yamazaki, Kazuto
- Katsutani, Naruo
- Takenaka, Osamu
- Clark, Richard
- Matsuura, Fumiyoshi
- Emori, Eita
- Yoshikawa, Seiji
- Kira, Kazunobu
- Ikuta, Hironori
- Okada, Toshimi
- Saeki, Takao
- Asano, Osamu
- Tanaka, Isao
Producer: 20061212
In:
European journal of pharmacology vol. 548
Availability: No items available.
|
|
|
2935.
|
|
|
|
2936.
|
|
|
|
2937.
|
|
|
|
2938.
|
Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. [electronic resource] by
- Jia, Lee
- Gorman, Gregory S
- Coward, Lori U
- Noker, Patricia E
- McCormick, David
- Horn, Thomas L
- Harder, J Brooks
- Muzzio, Miguel
- Prabhakar, Bellur
- Ganesh, Balaji
- Das Gupta, Tapas K
- Beattie, Craig W
Producer: 20111003
In:
Cancer chemotherapy and pharmacology vol. 68
Availability: No items available.
|
|
|
2939.
|
|
|
|
2940.
|
|